Supplier
California Specialty Pharmacy LLC
California Specialty Pharmacy LLC was paid $8.40M by Medicaid between Dec 2018 and Nov 2024, across 13 billing codes. Its largest line is J0135, Injection, adalimumab, 20 mg — 56% of everything it billed.
33Billing provider infoCALIFORNIA SPECIALTY PHARMACY LLC
WHITTIER, CA 90601
WHITTIER, CA 90601
33aNPI1114239332assigned 07/02/2010
33bProvider typePharmacy
28Total paid$8.40M
24GClaims5,134
24DCodes billed13
24AFirst – last monthDec 2018 – Nov 2024
Compared with peers
Next to other Pharmacy providers in California
Rank by total paid#6 of 179
Median peer was paid$2K
This provider vs. median4,761×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14 | $67K | |
| 2019 | 306 | $606K | |
| 2020 | 1,484 | $2.60M | |
| 2021 | 2,295 | $4.46M | |
| 2022 | 221 | $165K | |
| 2023 | 154 | $107K | |
| 2024incomplete | 660 | $386K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0135 | Injection, adalimumab, 20 mg | 56% | 1,125 | 1,040 | $4.73M |
| J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14% | 536 | 486 | $1.15M |
| J3490 | Unclassified drugs | 10% | 1,494 | 1,394 | $853K |
| J3590 | Unclassified biologics | 8.6% | 473 | 444 | $724K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 7.1% | 622 | 619 | $593K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1.6% | 253 | 165 | $131K |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 1.4% | 238 | 107 | $117K |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | <1% | 31 | 24 | $42K |
| 90750 | <1% | 137 | 137 | $33K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 122 | 54 | $27K |
| 0011A | <1% | 26 | 26 | $1K | |
| 0012A | <1% | 20 | 20 | $800.00 |
1 more codes
| S9542 | Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 57 | $26.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRIDNER, GEORGE (PRESIDENT/CEO)